Return to search

Ethical perspectives on surveillance and preventive strategies for HIV/AIDS in South Africa

Thesis (MPhil)-- University of Stellenbosch, 2000 / ENGLISH ABSTRACT: It is a well-known fact that the sub-Saharan Africa is a continent most affected by HIV/AIDS.
The HIV/AIDS pandemic has in other words become our disease. For many of us, this fact
may be difficult to fully accept. There are elements of prejudice in our reactions. Ignorance
and intolerance can be found around the world. Therefore, by presenting the facts about
HIV/AIDS, this assignment challenges the misconceptions and focuses on the profound
dilemmas confronting society.
I think the success in combating the HIV/AIDS pandemic could be found in President Thabo
Mbeki's terminology "Partnership against HIV/AIDS". In his speech, the President appealed
to both the private and public sectors and all South Africans to work together with greater
determination than before to fight against HIV infection and AIDS. Arguably, this was the
best speech President Thabo Mbeki ever made on HIV/AIDS on October 9, 1998. Back then,
the government seems to have had a direction and led from the front in the battle against
HIV/AIDS.
The title of this thesis reads: "Ethical perspectives on surveillance and preventive strategies
for HIV/AIDS in South Africa". Presently, the South African Government through the
Ministry of Health is seriously considering making AIDS a notifiable medical condition. This
is a serious and a controversial move that has serious ethical and legal implications that will
be discussed. Should partners of HIV-infected individuals be informed? If the answer is on
the affirmative, who should inform them? I am also looking at the ethical obligation of health
care workers to treat HIV/AIDS patients despite the fear of being accidentally infected. Tough
questions need to be asked. Should health workers be informed of the HIV status of every
patients they treat? On the other hand, some patients have some fears too that HIV-infected
health professionals may infect them. Again, the fundamental ethical concerns related to
confidentiality, privacy, the right to treatment will also be discussed. The country is divided
on this issue. Ethical principles are directly involved in such a decision, for instance, the
principle of confidentiality, respect for autonomy and informed consent. How can the
government go about implementing this without disregarding these fundamental ethical
requirements?Another ethical issue that comes to mind regarding HIV/AIDS concerns AIDS vaccine trials,
which are so far dominantly manufactured in 'developed countries' while subjects of these
trials are from 'third world' or 'developing countries '. The ethical concerns here are: How
will informed consent be protected, especially where subjects of the trials are not educated
and do not understand the terms used? What are the cost-effects or benefits of such trials?
What are the risks involved? Together with this, other issues include ethical debates
concerning market prices of drugs, which are too expensive for poorer countries and
affordable for richer countries.
Finally, this work does not treat everything that needs to be dealt with insofar as HIV/AIDS is
concerned. However, I hope that this thesis will contribute (in a small way) in making people
appreciate the ethical dilemmas that are presented by HIV/AIDS. / AFRIKAANSE OPSOMMING: Dit is algemeen bekend dat Afrika suid van die Sahara die gebied is met die hoogste
voorkoms van MIV/vIGS. Die MIV/VIGS-pandemie het dus ons siekte geword. Dit is
vir baie van ons moeilik om hierdie feit te aanvaar, en ons reaksies is dikwels
bevooroordeeld. Onkunde en onverdraagsaamheid oor MIV/vIGS word trouens
wereldwyd aangetref. Hierdie verhandeling Ie klem op die feite van MIV/VIGS, en
konfronteer sodoende hierdie wanopvattings terwyl daar gefokus word op die diepgaande
dilemmas waarmee die samelewing gekonfronteer word.
President Thabo Mbeki se woorde "Vennootskap teen MIV/VIGS" verwoord myns
insiens die enigste oplossing vir die MIV/VIGS-pandemie. Die President doen in sy
toespraak 'n beroep op al1e Suid-Afrikaners, in private en openbare sektore, om met
groter determinasie saam te veg teen MIV-infeksie en VIGS; Hierdie toespraak, gelewer
op 9 Oktober 1998, toe die regering klaarblyklik nog rigting gehad het en op die
voorfront was in die styd teen MIV/VIGS, was moontlik President Thabo Mbeki se beste
ooit oor die onderwerp MIV/VIGS.
Die titel van hierdie verhandeling is "Etiese perspektiewe ten opsigte van waarnemende
en voorkomende strategiee vir MIV/VIGS in Suid-Afrika". Die Suid-Afrikaanse
regering, by monde van die Ministerie van Gesondheid, oorweeg dit tans sterk om VIGS
'n aanmeldbare mediese kondisie te verklaar. Die ernstige etiese en regsimplikasies van
so 'n daadwerklike en kontroversiele stap sal in die verhandeling bespreek word. Behoort
die rnetgesel1e van MIV-positiewe persone ingelig te word? Indien wei, wie moet hulle in
kennis stel? Daar sal ook gekyk word na die etiese verpligting van
gesondheidsorgwerkers om MIV/VIGS-pasiente te behandel ten spyte van hul1e vrees om
per ongeluk besmet te word. Indringende vrae moet gevra word. Behoort
gesondheidsorgwerkers ingelig te word oor die MIV-status van elke pasient wat hul1e
behandel? Aan die ander kant vrees sornmige pasiente dat hul1e deur MIV-positiewe
gesondheisorgwerkers besmet kan word. Die fundamentele etiese aangeleenthede
rakende vertroulikheid, privaatheid en die reg tot mediese behandeling sal ook bespreek word. Suid-Afrika is verdeeld oor hierdie kwessies. Etiese waardes, soos die beginsel van
vertroulikheid, respek vir outonomie en ingeligte goedkeuring is direk betrokke by
besluite oor etiese kwessies. Die regering kan nie hierdie aangeleenthede implementeer
sonder om die fundamentele etiese vereistes in ag te neem nie.
VIGS-entstofproefnemings is'n verdere etiese kwessie wat ter sprake kom. Hierdie
proefnemings word grotendeels deur "ontwikkelde" lande uitgevoer, tewyl die
proefpersone van "derdewereldse" of "ontwikkelende" lande afkomstig is. Die etiese
kwessies hierby betrokke is: hoe sal ingeligte goedkeuring beskerm word, veral wanneer
proefpersone onopgevoed is en nie die tersaaklike terme verstaan nie? Wat is die kosteeffektiwiteit
of voordele van hierdie proefnemings? Watter risiko's is betrokke? Die
etiese debat oor die markprys van medisyne, wat heel bekostigbaar vir ryk lande, maar
duur vir armer lande is, word ook aangeraak.
Hierdie verhandeling dek nie alle relevante kwessies wat betref MIV/VIGS nie. Tog hoop
ek dat dit 'n bydrae sal lewer tot mense se bewuswording van die etiese dilemmas wat
MIV/VIGS inhou.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:sun/oai:scholar.sun.ac.za:10019.1/16419
Date12 1900
CreatorsKoenane, Mojalefa Johannes
ContributorsVan Niekerk, Anton A., University of Stellenbosch. Faculty of Arts and Social Sciences. Dept. of Philosophy., Jacobs, Ivan
PublisherStellenbosch : University of Stellenbosch
Source SetsSouth African National ETD Portal
Languageen_ZA
Detected LanguageEnglish
TypeThesis
Format73 p.
RightsUniversity of Stellenbosch

Page generated in 0.0021 seconds